New device aims to prevent bedsores from breathing tubes
NCT ID NCT06533436
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a new device called AnchorFast for holding breathing tubes in place in intensive care patients. It compares AnchorFast to the current method using cords. The goal is to see if AnchorFast reduces skin sores, tube movement, and lung infections. 350 adults who need a breathing tube will take part.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- AnchorFast device
- What this could lead to
- If successful, AnchorFast could reduce pressure sores and tube movement in ICU patients, improving comfort and care.
- What could go wrong
- This is a single-center study with 350 participants, so results may not apply to all ICUs. The device may not significantly outperform current methods.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESCHAR are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hôpital Foch
RECRUITINGSuresnes, 92150, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Which breathing tube causes fewer throat injuries? new trial compares two designs
- Could a 'robotic cough' stop deadly pneumonia in ICU patients?
- New study tests safer dosing of Heart-Stabilizing drug during breathing tube insertion
- Fat grafting study for bedsores pulled before it began
- Massive global study aims to make Kids' anesthesia safer
- Can a special toothbrush stop pneumonia in ICU patients?